Key Personnel
Aidan Courtney (Chief Operating Officer)
Aidan is the Chief Operating Officer of Roslin Cells. Aidan has worked with a wide variety of high technology start-ups and early stage companies. In each case his role has been to help the founding scientists or engineers transform their novel technology into a strong business proposition. After graduating in Economics, Aidan qualified as a Chartered Accountant and worked for eight years in property finance, before moving over to the high tech sector. He recently completed a masters degree in law specialising in Intellectual Property law.
Paul De Sousa (Chief Scientific Officer)
Dr. Paul De Sousa has trained as a developmental and reproductive biologist, with a specific interest in mechanisms controlling the creation of developmentally competent eggs and embryos and cell regeneration. In 1998 he joined the Roslin Institute in Scotland where he began applying his basic research interests to animal biotechnology, In 2002 his group began focusing on the derivation of new human embryonic stem cells in accordance with emerging regulatory standards for therapeutic use. In 2005 he joined the University of Edinburgh as a Senior Research Fellow establishing a laboratory focused on the use of human embryonic stem cells in regenerative medicine and underpinning egg and embryo biotechnology. In concert with this he co-founded Roslin Cells Ltd.
Malcolm Bateman (Director)
Malcolm is a Chartered Management Accountant who spent about 30 years working in different parts of the UK and overseas with UK, US and German multinationals in the automotive and pharmaceutical sectors. He held a variety of financial posts but was latterly the Managing Director of major automotive component manufacturer. In recent years he has worked with and maintains directorships in a number of innovative emerging companies. Formerly the Director of Finance for the Roslin Institute, Malcolm is currently the CEO of the Roslin Foundation a role that includes being the CEO for its science park, the Roslin BioCentre, and a Director with its three spin outs Roslin Cells, Well Cow and Roslin Cellab. He is also a Director of Roslin Developments which is currently building a new research facility located at the University of Edinburgh's Easter Bush campus. He also holds directorships with organisations in the public and voluntary sectors.
Professor Marc Turner (Director)
Marc Turner is Professor of Cellular Therapy at the University of Edinburgh, Clinical Director and Consultant Haematologist in the Edinburgh and Aberdeen Blood Transfusion Centres and honorary Consultant Haematologist at the Royal Infirmary of Edinburgh. He qualified in Medicine from the University of Manchester in 1982 and trained in General Medicine and Haematology before moving into Transfusion Medicine. He obtained his PhD in human haematopoietic stem cell biology from the University of Edinburgh in 1995. He is a Fellow of the Royal College of Physicians of London, a Fellow of the Royal College of Physicians of Edinburgh, a Fellow of the Royal College of Pathologists and a Fellow of the Higher Education Academy. His research interests include immunohaematology, variant CJD transmission by blood and tissues and translational research in stem cell and regenerative medicine. His more general interests lie in managing the sometimes challenging interface between science, medicine and public health policy and in this regard he has provided specialist opinion to a number of national and international advisory committees and regulatory bodies. He is Associate Director of the Scottish Centre for Regenerative Medicine and a non-executive Director of the Scottish Stem Cell Network and Roslin Cells.
